Abstract：Objective To investigate the effects of vasoactive intestinal peptide (VIP) on the airway inflammation and its regulatory effect on Th17/Treg imbalance in asthmatic mice. Methods A total of 30 BALB/c mice were equally and randomly divided into three groups:control, asthma, and VIP. An acute asthmatic mouse model was established by sensitization and challenge with ovalbumin (OVA). The control group received normal saline instead of OVA. Before the challenge with OVA, the VIP group was administered VIP (20 μg/mL) by aerosol inhalation for 30 minutes. The bronchoalveolar lavage fluid (BALF) and the lung tissue were collected from mice. The pathological changes in the lung tissue were observed by hematoxylin and eosin staining. The levels of Th17/Treg-related cytokines in BALF were measured by enzyme-linked immunosorbent assay. The expression of retinoid-related orphan receptor gamma t (RORγt) and forkhead box P3 (Foxp3) were measured by real-time fluorescence quantitative PCR and immunohistochemistry. Results The histopathological results showed that the VIP group had milder symptoms of airway inflammation than the asthma group. The level of IL-17 in BALF in the asthma group was significantly higher than that in the control group and the VIP group (P < 0.01), but the level of IL-17 in the control group was significantly lower than that in the VIP group (P < 0.01). The level of IL-10 in BALF in the asthma group was significantly lower than that in the control group and the VIP group (P < 0.01, but the level of IL-10 in the VIP group was significantly higher than that in the control group (P < 0.01). The asthma group showed significantly higher expression levels of RORγt mRNA and protein in the lung tissue and significantly lower expression levels of Foxp3 mRNA and protein than the control group (P < 0.01). The VIP group had significantly lower expression levels of RORγt mRNA and protein in the lung tissue and significantly higher expression levels of Foxp3 mRNA and protein than the asthma group (P < 0.05). Conclusions The Th17/Treg imbalance may be closely related to the airway inflammation in asthmatic mice. VIP can improve airway inflammation by regulating the Th17/Treg imbalance in asthmatic mice.
KE Li-Qin,WANG Feng-Mei,LUO Yun-Chun. Effects of vasoactive intestinal peptide on airway inflammation and Th17/Treg balance in asthmatic mice[J]. CJCP, 2017, 19(6): 699-704.
Horak F, Doberer D, Eber E, et al. Diagnosis and management of asthma-Statement on the 2015 GINA Guidelines[J]. Wien Klin Wochenschr, 2016, 128(15-16):541-554.
[2]
Zhao J, Lloyd CM, Noble A. Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling[J]. Mucosal Immunol, 2013, 6(2):335-346.
[3]
Jiang H, Wu X, Zhu H, et al. FOXP3(+)Treg/Th17 cell imbalance in lung tissues of mice with asthma[J]. Int J Clin Exp Med, 2015, 8(3):4158-4163.
[4]
Groneberg DA, Springer J, Fischer A. Vasoactive intestinal polypeptide as mediator of asthma[J]. Pulm Pharmacol Ther, 2001, 14(5):391-401.
[5]
Jimeno R, Gomariz RP, Gutiérrez-Cañas I, et al. New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes[J]. Immunol Cell Biol, 2010, 88(7):734-745.
[6]
Olopade CO, Yu J, Abubaker J, et al. Catalytic hydrolysis of VIP in pregnant women with asthma[J]. J Asthma, 2006, 43(6):429-432.
Lee MY, Seo CS, Lee NH, et al. Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model[J]. Int Immunopharmacol, 2010, 10(11):1374-1379.
[9]
Noval Rivas M, Chatila TA. Regulatory T cells in allergic diseases[J]. J Allergy Clin Immunol, 2016, 138(3):639-652.
[10]
Deng Y, Chen W, Zang N, et al. The antiasthma effect of neonatal BCG vaccination does not depend on the Th17/Th1 but IL-17/IFN-γ balance in a BALB/c mouse asthma model[J]. J Clin Immunol, 2011, 31(3):419-429.
[11]
Gasch M, Goroll T, Bauer M, et al. Generation of IL-8 and IL-9 producing CD4+ T cells is affected by Th17 polarizing conditions and AHR ligands[J]. Mediators Inflamm, 2014, 2014:182549.
[12]
Szema AM, Hamidi SA, Lyubsky S, et al. Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP[J]. Am J Physiol Lung Cell Mol Physiol, 2006, 291(5):L880-L886.
[13]
Deng S, Xi Y, Wang H, et al. Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis[J]. Cell Immunol, 2010, 265(2):105-110.
